274 related articles for article (PubMed ID: 2975420)
1. [Types of cellular antitumor cytotoxicity].
Lomakin MS; Maĭskiĭ IN
Vopr Onkol; 1988; 34(12):1422-32. PubMed ID: 2975420
[No Abstract] [Full Text] [Related]
2. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity].
Janiak M; Lipski S
Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997
[No Abstract] [Full Text] [Related]
3. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
4. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells and tumor immunity: 1985.
Herberman RB
Year Immunol; 1986; 2():254-60. PubMed ID: 3033946
[No Abstract] [Full Text] [Related]
6. Immunologic monitoring of the renal transplant recipient.
Suthanthiran M; Garovoy MR
Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
[No Abstract] [Full Text] [Related]
7. [Lectin-dependent cytotoxicity of human peripheral blood lymphocytes].
Bykovskaia SN; Blokhina NG; Vasil'eva ER; Agafonov VA; Raushenbakh MO
Biull Eksp Biol Med; 1983 Mar; 95(3):48-51. PubMed ID: 6219723
[TBL] [Abstract][Full Text] [Related]
8. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
Rupniewska ZM; Adamczyk MB
Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
[No Abstract] [Full Text] [Related]
9. Targeting and activation of cytotoxic lymphocytes.
Segal DM; Snider DP
Chem Immunol; 1989; 47():179-213. PubMed ID: 2692611
[No Abstract] [Full Text] [Related]
10. Immunology. Stress, NK receptors, and immune surveillance.
Pardoll DM
Science; 2001 Oct; 294(5542):534-6. PubMed ID: 11567108
[No Abstract] [Full Text] [Related]
11. Immunomodulatory and therapeutic properties of bestatin in mice.
Talmadge JE; Lenz BF; Pennington R; Long C; Phillips H; Schneider M; Tribble H
Cancer Res; 1986 Sep; 46(9):4505-10. PubMed ID: 2942238
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cytotoxic cells generated in the autologous mixed lymphocyte reaction.
Hausman PB; Moody CE; Weksler ME
Behring Inst Mitt; 1983 May; (72):78-86. PubMed ID: 6242344
[No Abstract] [Full Text] [Related]
13. In vitro tests of cellular immunity in man.
Herberman RB
Invest Cell Pathol; 1978; 1(3):227-48. PubMed ID: 160405
[TBL] [Abstract][Full Text] [Related]
14. [Cell mediated cytotoxic activities in ataxia-telangiectasia with T cell deficiency].
Tsuge I; Matsuoka H; Okada J; Mizuno T; Matsuoka M; Torii S; Kodera Y; Takahashi T
Arerugi; 1984 Oct; 33(10):909-16. PubMed ID: 6335392
[No Abstract] [Full Text] [Related]
15. Role of activated natural killer and CD4+, CD8+ cells in the cellular rejection of a discordant xenograft.
Elsen M; Soares M; Latinne D; Cornet A; Bazin H
Transplant Proc; 1993 Feb; 25(1 Pt 1):447-9. PubMed ID: 8438373
[No Abstract] [Full Text] [Related]
16. [Natural cytotoxic cells (NK cells)].
Frydecka I
Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1343-5. PubMed ID: 6371740
[No Abstract] [Full Text] [Related]
17. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
18. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.
Trinchieri G; Santoli D; Granato D; Perussia B
Fed Proc; 1981 Oct; 40(12):2705-10. PubMed ID: 6169557
[TBL] [Abstract][Full Text] [Related]
20. Tumor progression in vitro: the paradoxical natural antibody and complement-selected phenotype.
Chow DA; Chan J
Nat Immun Cell Growth Regul; 1987; 6(4):189-204. PubMed ID: 3683415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
